- SCNT creates embryos by transferring a body cell's nucleus into an enucleated egg.
- Dolly the sheep proved adult cells retain full developmental potential.
- Human embryonic stem cells were first derived via SCNT in 2013.
Somatic cell nuclear transfer (SCNT) is a laboratory technique that creates an embryo by moving the nucleus of a body cell into an egg cell whose own nucleus has been removed. The resulting embryo carries the same nuclear DNA as the donor cell, making SCNT the primary method for cloning mammals and a tool for generating patient-matched stem cells.
Why It Matters
SCNT answered a question that had divided biologists for over a century: does a fully differentiated adult cell still contain all the genetic instructions needed to build an entire organism? Before 1996, the prevailing view held that once a cell specialized (becoming a skin cell, a muscle cell, a mammary gland cell) it could not reverse course. The birth of Dolly the sheep at the Roslin Institute in Edinburgh proved otherwise.
Key figure
1 in 277
Dolly's success rate: one live birth from 277 nuclear transfer attempts
That proof matters beyond cloning itself. It established that the genome of an adult cell retains the full blueprint for development. The egg's cytoplasm can reset, or "reprogram," a specialized nucleus back to an embryonic state. This insight reshaped how biologists think about epigenetic inheritance and cellular identity.
SCNT also opened a path toward therapeutic cloning: creating patient-matched embryonic stem cells without reproduction. In 2013, Masahito Tachibana and Shoukhrat Mitalipov at Oregon Health and Science University used SCNT to derive the first human embryonic stem cell lines from adult skin cells. Those cells could, in principle, be coaxed into replacement tissues that a patient's immune system would not reject.
Today, induced pluripotent stem cells (iPSCs) have become a simpler alternative for many applications. Yet SCNT remains the only technique proven to produce a live-born clone from an adult mammal, and it continues to inform efforts in de-extinction and conservation biology.
How It Works
The process begins with two cells. The first is a somatic cell, any cell in the body except sperm or egg, taken from the animal to be cloned. The second is an oocyte (egg cell) collected from a donor female of the same species.
A researcher removes the oocyte's nucleus using a fine glass pipette, a procedure called enucleation. This strips the egg of its original genetic material while preserving its cytoplasm, the molecular machinery that drives early embryonic development.
The nucleus from the somatic cell is then inserted into the enucleated egg, either by direct injection or by placing the somatic cell against the egg and fusing them with a brief electrical pulse. The egg's cytoplasmic factors begin reprogramming the transplanted nucleus, silencing the genes that made it a specialized cell and reactivating the genes needed for embryonic growth.
Key figure
1938
Year Hans Spemann first proposed nuclear transfer in embryology
If reprogramming succeeds, the reconstructed egg divides and develops into a blastocyst within days. For reproductive cloning, this blastocyst is implanted into a surrogate mother. For therapeutic cloning, stem cells are harvested from the blastocyst's inner cell mass.
Key Context
The concept predates the technology by decades. German embryologist Hans Spemann proposed transplanting a nucleus from a differentiated cell into an enucleated egg in his 1938 book Embryonic Development and Induction. He called it a "fantastical experiment." The tools to attempt it did not exist until Robert Briggs and Thomas King developed a practical protocol using frog embryos in 1952.
Dolly's story carries a detail that underscores how difficult SCNT remains. Ian Wilmut, Keith Campbell, and their colleagues at the Roslin Institute created 277 reconstructed embryos. Of those, 29 developed well enough to be implanted into surrogate ewes. Only one pregnancy reached term. Dolly, born July 5, 1996, was named after the singer Dolly Parton because the donor cell came from a mammary gland. The result was published in Nature on February 27, 1997.
FAQ
Is somatic cell nuclear transfer the same as CRISPR gene editing?
No. SCNT copies an existing genome into a new embryo without altering the DNA sequence. CRISPR edits specific genes within an existing genome. They are distinct techniques, though researchers sometimes combine them, using CRISPR to modify a cell before cloning it via SCNT.
Why is SCNT efficiency so low?
Reprogramming a specialized nucleus back to an embryonic state requires the egg cytoplasm to erase and reset thousands of epigenetic marks. Incomplete reprogramming causes most SCNT embryos to fail during early development. In Dolly the sheep, the success rate was 0.4%. Rates have improved in some species but remain below 20% even under optimal conditions.
Has SCNT been used to clone a human?
No. While human embryonic stem cells have been derived from SCNT embryos (Tachibana and Mitalipov team, Oregon, 2013), no one has used SCNT to produce a cloned human being. Reproductive human cloning is banned or restricted in most countries.
Could SCNT bring back extinct species?
In principle, yes, if intact nuclei from an extinct species can be recovered and a closely related species can provide compatible egg cells. A team in Spain produced a clone of the extinct Pyrenean ibex (bucardo) in 2003 using SCNT, but the animal died minutes after birth due to a lung defect. The technique remains central to current de-extinction efforts.
Sources
- Primary Research: Viable offspring derived from fetal and adult mammalian cells (Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J., Campbell, K.H.S., Nature, 1997)
- Primary Research: Human embryonic stem cells derived by somatic cell nuclear transfer (Tachibana, M. et al., Cell, 2013)
- Additional Context:
- Somatic cell nuclear transfer (Britannica)
- Somatic Cell Nuclear Transfer in Mammals (1938-2013) (Embryo Project Encyclopedia)
Fact Check: Claim-by-Claim Verification Verified
All core claims verified against primary sources. Two minor errors (name spelling, date) corrected during editorial check.
Sources used for verification
- Viable offspring derived from fetal and adult mammalian cells - nature.com
- Human embryonic stem cells derived by somatic cell nuclear transfer - cell.com
- Somatic cell nuclear transfer - britannica.com
- SCNT in Mammals 1938-2013 - embryo.asu.edu
